相关实验视频
Updated: Jul 6, 2025

07:16
Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
Published on: March 14, 2014
14.1K
NCAPG2通过STAT3/c-MYC信号传递促进前列腺癌恶性和干性
Enchong Zhang1, Zhengjie Chen2,3, Wangmin Liu1
1Department of Urology, Shenjing Hospital of China Medical University, Shenyang, China.
Journal of translational medicine
|January 3, 2024
概括
NCAPG2在前列腺癌 (PCa) 中表达高,并促进其进展和干性. 通过STAT3/c-MYC途径准NCAPG2为PCa提供了一个潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 前列腺癌 (PCa) 是男性癌症死亡的主要原因,发病率越来越高.
- 对于管理PCa进展和复发的新生物标志物和治疗点有着至关重要的需求.
研究的目的:
- 研究NCAPG2在前列腺癌中的临床意义和分子机制.
- 评估NCAPG2作为PCa的潜在治疗点.
主要方法:
- 对PCa中NCAPG2表达的公共数据集和组织微阵列的分析.
- 在体外测试 (增殖,迁移,细胞周期,茎状) 和体内异种移植模型来评估NCAPG2的功能.
- 协同质量标签 (TMT) 定量蛋白质组学和分子测定 (co-IP,ChIP) 以阐明STAT3/c-MYC信号通路.
主要成果:
- 在PCa中,NCAPG2显著上调,与进展和不良预后相关.
- 在体内,NCAPG2过度表达促进了PCa细胞的攻击性和瘤生长.
- NCAPG2通过STAT3信号通路激活c-MYC表达,并增强癌症干细胞的特性.
结论:
- NCAPG2是PCa的预后生物标志物.
- NCAPG2通过STAT3/c-MYC轴驱动PCa恶性和癌症干.
- NCAPG2代表了前列腺癌的一个有前途的治疗标.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K

